NYU Fertility Center Presentations at American Society for Reproductive Medicine Annual Conference
October 27, 2010
The American Society for Reproductive Medicine (ASRM) held their annual conference in Denver, Colorado from October 23 - 27. The NYU Fertility Center physicians and researchers helped to celebrate this year's theme, Taking Reproductive Medicine to New Heights!, with an impressive collection of Oral, Poster and Video presentations at the conference, as well as an interactive session led by Dr. Nicole Noyes.
Interactive Session - Unique Challenges in the Care of the Oncofertility Patient
Nicole L. Noyes, M.D. (Chair), New York University School of Medicine
Clarisa R. Garcia, M.D., University of Pennsylvania
Fertility preservation ranks as one of the greatest concerns for women and girls newly diagnosed with a treatable malignancy. As technological advancements continue in this field, more patients are pursuing fertility preservation than ever before. Consequently, reproductive endocrinologists must be keenly aware of particular clinical situations that may be encountered. In this session, we will present a series of clinical scenarios to illustrate management complexities and offer suggestions for optimal patient care.
Oral Presentations
O-55: Does Isolated Teratozoospermia Warrant the Use of Intracytoplasmic Sperm Injection (ICSI)?
O-84: What's the Score?: A Quantitative Means to Assess Embryo Quality (EQ).
O-95: Is Bigger Better: The Association Between Follicle Size and Livebirth Rate Following IVF.
O-100: Generation and Characterization of Disease-Specific Human Embryonic Stem Cells from Genetically Abnormal Embryos.
O-142: Are We Underestimating the Prevalance of Aneuploidy-Related Miscarriages? A Description of Cytogenetic Results from Products of Conception (POC) After Dilation and Curettage (D&C).
O-171: Do IVF or IVF Technologies Increase Risk of Miscarriage (MC) and Aneuploidy (ANP)? Ten Year Outcome Analysis of ICSI and Extended Embryo Culture at a Large, University-Based IVF Center.
O-271: Validation and First Clinical Application of Karyo-Mapping for Preimplantation Diagnosis (PGD) of Gaucher Disease Combined with 24 Chromosome Screening.
O-276: Preimplantation Genetic Diagnosis Using Array CGH Significantly Increases Ongoing Pregnancy Rates Per Transfer.
O-280: Elective Single Blastocyst Transfer (eSBT) Eliminates Twinning Without Compromising the Pregnancy Rate (PR) in Good Prognosis Patients.
O-283: Leader of the Pack: Lead Embryo Development on Day 5 (D5) Best Determines Outcome in Oocyte Donation (OD) Cycles.
Video Presentation
V-7: Time-Lapse Imaging of Tripronuclear Embryos: Mechanisms of Formation and Abnormal Development.
Poster Presentations
P-29: Evaluation of the Meitoic Spindle (MS) and Zona Pellucida (ZP) to Identify a Relationship Between Fertility and Malignancy in Women Undergoing Oocyte Cryopreservation (OC).
P-68: Transfer (ET) of Previously Cryopreserved Oocytes or Zygotes Results in Pregnancy Outcomes Similar to that of Fresh Blastocysts (Blast) in IVF.
P-73: Clinical Outcomes of Natural Versus Programmed Frozen-Thawed Embryo Transfers (FET): A 5-Year Review.
P-80: Oocyte Cryopreservation: An Alternative Model for Gamete Donation.
P-102: Does Newly Available 24-Chromosome (24C) Preimplantation Genetic Screening (PGS) Improve IVF Outcomes in Patients at Risk for Aneuploidy? First Year's Experience at a Large, University-Based Center.
P-294: Preimplantation Genetic Diagnosis for Recurrent Pregnancy Loss Also Reduces Miscarriage Risk for Young Women.
P-326: What is a Normal Thyroid Stimulating Hormone (TSH) Level? Effects of Stricter TSH Thresholds on Pregnancy Outcomes After IVF.
P-332: Effect of Autoimmune Thyroid Disease (AITD) in Older, Euthyroid Infertile Women Undergoing In Vitro Fertilization (IVF).
P-431: Is Increasing Endometrial Lining Thickness Advantageous or Detrimental to Pregnancy Outcomes in Oocyte Donation Cycles (OD-IVF)?
P-575: Estradiol (E2), Progesterone (P), and Human Chorionic Gonadotropin (hCG) as Predictors of Pregnancy Outcome in In-Vitro Fertilization (IVF).
P-582: Single Blastocyst Transfer Minimizes the Likelihood of Multiple Pregnancies in Good Prognosis Young IVF Patients Without Compromising Pregnancy Rate.
P-586: Elective Single Blastocyst Transfers (eSBT) in Oocyte Donor IVF Cycles (OD-IVF) Result in a Reduction of Multiples Without Compromising the Live Birth Rate (LBR).
